Literature DB >> 1520059

Detection of deep vein thrombosis with impedance plethysmography and real-time compression ultrasonography in hospitalized patients.

H Heijboer1, A Cogo, H R Büller, P Prandoni, J W ten Cate.   

Abstract

BACKGROUND: Serial testing with impedance plethysmography or compression ultrasonography has been demonstrated to be feasible and accurate for the detection of deep vein thrombosis (DVT) in symptomatic outpatients, and these techniques are replacing contrast venography in this patient category. Limited data, however, are available on the clinical utility of these noninvasive tests in symptomatic hospitalized patients. The objectives of our study were to determine the feasibility of ascending contrast venography and to evaluate the accuracy of these two noninvasive methods for the detection of DVT in symptomatic hospitalized patients.
METHODS: A prospective, "blind" comparison of impedance plethysmography and compression ultrasonography with ascending contrast venography was performed in consecutive hospitalized patients with clinically suspected DVT of the leg.
RESULTS: Of the 127 potentially eligible patients, 44 had to be excluded; 25 of these could not undergo venography (feasibility of venography, 80.3%). The sensitivity, specificity, and positive and negative predictive values of impedance plethysmography for proximal DVT were 96%, 83%, 82%, and 97%, respectively. For compression ultrasonography, these measures for proximal DVT were 97%, 86%, 87%, and 97%, respectively. The overall prevalence of DVT was 53%, of which 85% was located proximally.
CONCLUSIONS: Contrast venography cannot be performed in about 20% of consecutive symptomatic patients. Both impedance plethysmography and compression ultrasonography are feasible and valid alternatives to contrast venography in the diagnostic treatment of these patients.

Entities:  

Mesh:

Year:  1992        PMID: 1520059

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  8 in total

1.  Meta-analysis of plethysmography and rheography in the diagnosis of deep vein thrombosis.

Authors:  T Locker; S Goodacre; F Sampson; A Webster; A J Sutton
Journal:  Emerg Med J       Date:  2006-08       Impact factor: 2.740

2.  A Noninvasive Approach for the Treatment of Patients with Suspected Pulmonary Embolism.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

3.  Predictors of a positive duplex scan in patients with a clinical presentation compatible with deep vein thrombosis or cellulitis.

Authors:  Curtis E Rabuka; Laurent Y Azoulay; Susan R Kahn
Journal:  Can J Infect Dis       Date:  2003-07

4.  Safety of withholding anticoagulation in pregnant women with suspected deep vein thrombosis following negative serial compression ultrasound and iliac vein imaging.

Authors:  Wee-Shian Chan; Frederick A Spencer; Agnes Y Y Lee; Sanjeev Chunilal; James D Douketis; Marc Rodger; Jeffrey S Ginsberg
Journal:  CMAJ       Date:  2013-01-14       Impact factor: 8.262

5.  Cost-effectiveness of enoxaparin versus warfarin prophylaxis against deep-vein thrombosis after total hip replacement.

Authors:  B J O'Brien; D R Anderson; R Goeree
Journal:  CMAJ       Date:  1994-04-01       Impact factor: 8.262

6.  Systematic review and meta-analysis of the diagnostic accuracy of ultrasonography for deep vein thrombosis.

Authors:  Steve Goodacre; Fiona Sampson; Steve Thomas; Edwin van Beek; Alex Sutton
Journal:  BMC Med Imaging       Date:  2005-10-03       Impact factor: 1.930

Review 7.  Peripheral vascular disease assessment in the lower limb: a review of current and emerging non-invasive diagnostic methods.

Authors:  Elham Shabani Varaki; Gaetano D Gargiulo; Stefania Penkala; Paul P Breen
Journal:  Biomed Eng Online       Date:  2018-05-11       Impact factor: 2.819

8.  Diagnostic accuracy of three ultrasonography strategies for deep vein thrombosis of the lower extremity: A systematic review and meta-analysis.

Authors:  Noémie Kraaijpoel; Marc Carrier; Grégoire Le Gal; Matthew D F McInnes; Jean-Paul Salameh; Trevor A McGrath; Nick van Es; David Moher; Harry R Büller; Patrick M Bossuyt; Mariska M G Leeflang
Journal:  PLoS One       Date:  2020-02-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.